Matthew P. Miller

Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand ¹⁸F-AH111585 in Breast Cancer Patients

Laura Kenny, R. Charles Coombes, Inger Oulie et al. · Journal of Nuclear Medicine · 2008 · 277 citations · Full text

The Impact of Positron Emission Tomography with ¹⁸ F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

Gerald L. Andriole, Lale Kostakoğlu, Albert Chau et al. · The Journal of Urology · 2018 · 148 citations · Full text

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer et al. · European Urology · 2023 · 86 citations · Full text

The Biodistribution and Radiation Dosimetry of the Arg-Gly-Asp Peptide ¹⁸F-AH111585 in Healthy Volunteers

Brian J. McParland, Matthew P. Miller, T J Spinks et al. · Journal of Nuclear Medicine · 2008 · 66 citations · Full text

Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial

Andrew Scarsbrook, David Bottomley, Eugene Teoh et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 63 citations · Full text